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Abstract
Since the effect of smoking on plasma leptin has been divergent in clinical trials, which might have occurred due to selection
of heterogeneous study populations, we investigated whether there is such an association in a group of healthy, non-obese,
young male adults.
A total of 54 smokers (mean age: 21.1891.62; body mass index (BMI): 19.6090.85) and 26 non-smokers (mean age
21.6993.0; BMI: 21.5991.39) with similar daily physical activities and diet and without any documented disease were
enrolled, and their plasma leptin levels were determined for the comparison between the two groups.
The mean BMI and plasma leptin of smokers were significantly lower than in non-smokers. Plasma leptin in the smokers
group correlated inversely with BMI and the amount of daily smoking. Below BMI 20 kg/m
2 and between 20.0 and
20.9 kg/m
2 the plasma leptin levels in smokers were significantly lower when compared to non-smokers.
Plasma leptin is decreased in healthy, young non-obese male smokers independently of the amount of body fat. High
amount of smoking is associated with lower serum leptin as well.
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Introduction
Long-time smoking is characterized by reduced
body-weight (13), while cessation of smoking
usually leads to rapid weight-gain (47). The prob-
able causes of weight-gain are increased food intake,
decreased resting metabolic rate and physical activ-
ity, and increased lipoprotein lipase activity (7).
Moreover, weight concerns affect the motivation to
quit smoking (8). However, the molecular factors
regulating food intake and body-weight in smokers
have not yet been clearly identified. Leptin, a
polypeptide hormone secreted by adipocytes, has
been shown to influence body-weight mainly by
reducing food intake and increasing energy expen-
diture through central and peripheral mechanisms
(911). Leptin has a diurnal rhythm and a positive
correlation with the degree of adiposity, body mass
index (BMI), and circulating insulin levels (1215).
Gender differences also determine the plasma leptin
levels (16).
Since there is a close association of body-weight
with smoking and serum leptin, many authors have
investigated the interaction between leptin and
smoking. However, the effect of smoking on plasma
leptin has been divergent in clinical trials. Some
studies have mentioned decreased serum leptin in
smokers (1723) while others found no difference
between smokers and non-smokers regarding circu-
lating leptin (2426). Since these controversial
results might have occurred due to selection of study
populations in those studies, which frequently in-
cluded heterogeneous groups of individuals regard-
ing age, gender, and BMI, we investigated the
association between plasma leptin levels and smok-
ing in a homogenous group of healthy, non-obese,
young male adults with appropriate controls.
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Study population
The study was conducted on 80 young, non-obese
male adults (mean age: 21.3592.16 years; BMI:
20.2591.41) who were allocated into two groups
according to their smoking habits as 54 smokers
(mean age: 21.1891.62; BMI: 19.6090.85) and
26 non-smokers (mean age 21.6993.0; BMI:
21.5991.39). Being a smoker was defined as smok-
ing cigarettes for at least 2 years, with more than
5 cigarettes daily. Only a ‘never-smoker’ was ac-
cepted as a non-smoker. No ex-smoker was included
in any group. The participants of the study were the
soldiers from a troop and had similar daily physical
activities and diet for at least 6 months. None of the
participants had any documented disease nor were
taking any medication, including over-the-counter
drugs. Physical activity levels and glucose tolerance
status were similar for smokers and non-smokers.
The study was approved by the Ethics Commit-
tee of Gulhane Medical School. All subjects gave
written informed consent before entrance in the
study.
According to the daily numbers of cigarettes, the
patients were grouped as heavy smokers (n12)
(more than 20 cigarettes a day), moderate smokers
(n12) (between 10 and 20 cigarettes a day), and
mild smokers (n30) (fewer than 10 cigarettes a
day).
Anthropometric measurements
Height and weight were determined with the parti-
cipant wearing underpants, without shoes. BMI was
calculated as weight (kg)/height (m)
2.
Analyses
Overnight fasting venous blood samples were col-
lected at 08.00 for analysis of leptin in cold test tubes
containing 0.084 mL Ethylene Diamine Tetraacetic
Acid (EDTA) (0.34 mol/L). Leptin was measured by
a radioimmunoassay using Human Leptin IRMA
(DSL-23100 Leptin-Coated Tube Immunoradio-
metric Assay Kit) (Diagnostic Systems Laboratories
Inc., Texas, USA). Serum was stored at 308C
until analyses, and all measurements were performed
in duplicate.
Statistical analyses
All data are presented as mean9SD unless other-
wise noted. Student’s t test was used to compare the
parameters of the two groups. The associations
between serum leptin levels and BMI or daily
cigarette number were investigated by Spearman’s
correlation analysis.
Results
Age, blood pressure, total cholesterol, triglyceride,
and fasting glucose levels were all similar in both the
smoker and non-smoker groups. The mean BMI of
smokers was lower than non-smokers (19.609
0.85 kg/m
2 versus 21.5991.39 kg/m
2)( PB0.001).
The plasma leptin levels in the smoker group were
significantly lower than in non-smokers (3.479
1.1 ng/mL versus 6.6391.5 ng/mL) (P0.006).
Plasma leptin in the smokers group correlated inver-
selywithBMI(r0.83,PB0.001)andtheamountof
daily smoking (r0.77, PB0.001) (Figure 1).
The smokers and non-smokers were subanalyzed
according to BMI values. Below 20 kg/m
2 (n22;
12 smokers, 10 non-smokers) and between 20.0 and
20.9 kg/m
2 (n30; 18 smokers, 12 non-smokers) of
BMIs, the plasma leptin levels in smokers were
significantly lower (P0.009 and P0.024, respec-
tively) when compared to non-smokerswith the same
BMI values. Since there were only two individuals in
the smoker group who had a BMI above 21, compar-
ison of plasma leptin levels in the subjects having
BMIs higher than this value was not performed.
Discussion
The present study, which was designed to search
for any relation between smoking and plasma leptin
levels in healthy and young non-obese males,
indicates that smokers have significantly lower
plasma leptin levels. Low leptin levels in smokers
compared to non-smokers within the similar BMI
interval suggest that smoking is associated with low
plasma leptin independently of the body fat con-
tent. Moreover, there was an inverse association
between the number of cigarettes smoked per day
and the level of plasma leptin.
Leptin, which plays an important role in body-
weight homeostasis through reducing food intake
and increasing thermogenesis, has been studied in
smokers widely. While a number of studies indicated
that smoking does not affect plasma leptin levels
(12,2426), some others reported lower plasma
leptin levels in smokers (17,18,2023). More con-
troversies exist considering the reports with in-
creased plasma leptin in smoking people (27,28).
Detailed analyses of these studies indicate selection
of study population as the most probable reason for
these conflicting results. For instance, Larsson et al.
166 B. Koc et al.found no relation between smoking habits and
plasma leptin levels in their study with postmeno-
pausal, Caucasian, non-obese smoking women (26).
Similar results were also reported in type 2 diabetic
smoking Japanese males (25). On the other hand,
Hodge et al. in a group of smokers in the South
Pacific Islands (17) and Wei et al. in non-Hispanic
whites and Mexican Americans (18) measured low
plasma leptin levels. Though these results led to a
question of an ethnicity-based association between
plasma leptin levels and smoking, Donahue et al.
reported in their large multiethnic study that ethni-
city did not establish a direct relation between
plasma leptin and life habits (20). According to their
study, cigarette smoking was associated with lower
plasma leptin levels in both men and women.
Another possible mechanism for the lower leptin
in smokers could be related to the fact that smoking
increases plasma catecholamines and free fatty acid
concentrations, and lipolysis which may decrease
leptin concentrations (2932). Also, the nicotinic
effect of smoking may alter the sensitivity of
hypothalamic leptin receptors and modulate leptin
synthesis and a reduction in body-weight (16,31,32).
The discrepant results could also be explained by
other factors such as diet, exercise and other lifestyle
habits, hormones, and inflammatory markers which
may also regulate leptin secretion (29).
In a recent study, leptin levels were significantly
higher in women compared with men, and for both
sexes were positively correlated with both BMI
and the well studied marker of inflammation C-
reactive protein (CRP) (33).
The link between smoking and insulin resistance
syndrome was well identified (16,3335). In addi-
tion, smoking can increase the release of catechola-
mines, cortisol, adrenocorticotrophic hormone, and
growth hormone, and alter the sympathetic system
activity (29,34). These effects may be responsible for
the decrement of insulin-mediated glucose uptake in
smokers (36,37). Correlation between fasting insulin
and leptin levels was also previously reported (38).
Thus, insulin resistance is likely to be associated with
regulation of leptin metabolism in smokers. On the
other hand, multiple regressions analysis of the study
of Donahue et al. revealed that the effect of smoking
on plasma leptin levels seems to be independent of
fasting insulin levels (20). Since no overweight
individual was included neither in the study nor
the control group, and all subjects were young and
fairly well exercised, we did not measure fasting
plasma insulin levels.
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Figure 1. Plasma leptin levels according to number of cigarettes per day.
Leptin levels in young non-obese males 167In conclusion, the present study indicates that
plasma leptin is decreased in healthy, young non-
obese male smokers independently of the amount of
body fat, and high amount of smoking is associated
with lower serumleptin.Thus,smokingappearstobe
among the direct modulators of leptin metabolism.
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